Charles River Laboratories International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.11.19	Charles River Laboratories to Present at Upcoming Investor Conferences (Businesswire)
23.10.19	Charles River Laboratories Announces Closing of Senior Notes Offering (Businesswire)
21.10.19	Charles River Laboratories Schedules Third-Quarter 2019 Earnings Release and Conference Call (Businesswire)
21.10.19	Charles River Laboratories Int'l, Inc. -- Moody's rates Charles River's unsecured notes Ba3; Ba2 CFR affirmed (Moodys)
21.10.19	Charles River Laboratories Announces Offering of $500 Million of Senior Notes (Businesswire)
16.10.19	Charles River Laboratories Demonstrates Industry-Leading Research at Neuroscience 2019 (Businesswire)
03.10.19	Charles River Laboratories Joins Dementia Consortium, Reaffirms Commitment to Neuroscience Research (Businesswire)
01.10.19	Charles River Laboratories Adds Virginia M. Wilson to Board of Directors (Businesswire)
09.09.19	Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio (Businesswire)
05.09.19	Charles River Laboratories to Host 3rd Annual World Congress (Businesswire)
03.09.19	Charles River Laboratories to Present at Baird and Morgan Stanley Investor Conferences (Businesswire)
31.07.19	Charles River Laboratories Q2 Profit Declines, Raises FY19 Adj. Earnings Outlook (RTTNews)
29.07.19	Ausblick: Charles River Laboratories International präsentiert Quartalsergebnisse (finanzen.net)
16.07.19	Charles River Laboratories Schedules Second-Quarter 2019 Earnings Release and Conference Call (Businesswire)
09.07.19	Charles River Laboratories to Open Flexible Vivarium Space for Clients in South San Francisco (Businesswire)
03.06.19	Charles River Laboratories to Present at Jefferies and Goldman Sachs Investor Conferences (Businesswire)
16.05.19	Charles River Laboratories Invests in Resero Analytics™ (Businesswire)
07.05.19	Charles River Laboratories Q1 Profit Rises; Reiterates FY19 Outlook (RTTNews)
07.05.19	Charles River Laboratories Announces First-Quarter 2019 Results (Businesswire)
05.05.19	Ausblick: Charles River Laboratories International legt Quartalsergebnis vor (finanzen.net)
29.04.19	Charles River Laboratories Completes the Acquisition of Citoxlab (Businesswire)
11.04.19	Charles River Laboratories Schedules First-Quarter 2019 Earnings Release and Conference Call (Businesswire)
09.04.19	Charles River Laboratories and CHDI Foundation Extend Huntington’s Disease Collaboration (Businesswire)
26.03.19	Charles River Laboratories Highlights Commitment to Oncology Research at 2019 AACR Annual Meeting (Businesswire)
04.03.19	Charles River Laboratories to Present at Raymond James and Barclays Investor Conferences (Businesswire)
14.02.19	Charles River Laboratories Int'l, Inc. -- Moody's says Charles River's acquisition of Citoxlab is credit negative (Moodys)
14.02.19	Charles River Laboratories Int'l, Inc. -- Moody's says Charles River's acquisition of Citoxlab is credit negative (Moodys)
13.02.19	Charles River Labs Q4 Results Top Estimates; Guides 2019 Adj EPS In Line (RTTNews)
13.02.19	Charles River To Acquire Citoxlab - Quick Facts (RTTNews)
13.02.19	Charles River Laboratories Announces Fourth-Quarter and Full-Year 2018 Results and Provides 2019 Guidance (Businesswire)
13.02.19	Charles River Laboratories Signs Binding Offer to Acquire Citoxlab (Businesswire)
11.02.19	Ausblick: Charles River Laboratories International zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
30.01.19	Charles River, Toxys Enter Deal To Offer Access To ToxTracker In North America (RTTNews)
30.01.19	Charles River Laboratories and Toxys Enter Agreement to Offer ToxTracker® in North America (Businesswire)
17.01.19	Charles River Laboratories Schedules Fourth-Quarter 2018 Earnings and 2019 Guidance Release and Conference Call (Businesswire)
16.01.19	Charles River Laboratories Selected for 2019 Bloomberg Gender-Equality Index (Businesswire)
11.01.19	Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug Discovery (Businesswire)
07.01.19	Charles River Laboratories to Present at J.P. Morgan Healthcare Conference (Businesswire)
27.11.18	Charles River Laboratories to Present at Evercore ISI Investor Conference (Businesswire)
13.11.18	Charles River Laboratories Continues Commitment to Oncology Drug Discovery (Businesswire)
07.11.18	Charles River Lab Updates 2018 Guidance - Quick Facts (RTTNews)
07.11.18	Charles River Laboratories Announces Third-Quarter 2018 Results (Businesswire)
05.11.18	Ausblick: Charles River Laboratories International stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
30.10.18	Charles River to Present Collaborative Methods at Neuroscience 2018 (Businesswire)
25.10.18	Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform (Businesswire)
16.10.18	Charles River Laboratories Awarded Five-Year, $95.7 Million Contract by the National Institute of Allergy and Infectious Diseases (Businesswire)
10.10.18	Charles River Laboratories Schedules Third-Quarter 2018 Earnings Release and Conference Call (Businesswire)
30.08.18	Charles River Laboratories to Present at September Investor Conferences (Businesswire)
08.08.18	Charles River Increases 2018 Revenue Growth, Earnings Guidance - Quick Facts (RTTNews)
08.08.18	Charles River Laboratories Announces Second-Quarter 2018 Results from Continuing Operations (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

17.12.24		Börse New York in Rot: S&P 500 startet mit Verlusten
13.11.24		Mittwochshandel in New York: S&P 500 bewegt schlussendlich im Plus
13.11.24		Handel in New York: S&P 500-Anleger greifen nachmittags zu
13.11.24		Aufschläge in New York: S&P 500 am Mittwochmittag im Plus
10.10.24		Anleger in New York halten sich zurück: S&P 500 fällt am Mittag zurück
25.09.24		Schwache Performance in New York: So entwickelt sich der S&P 500 am Mittwochmittag
12.08.24		Montagshandel in New York: S&P 500 beginnt die Montagssitzung in der Verlustzone
07.08.24		Handel in New York: S&P 500 fällt letztendlich zurück

17.12.24

Börse New York in Rot: S&P 500 startet mit Verlusten

13.11.24

Mittwochshandel in New York: S&P 500 bewegt schlussendlich im Plus

13.11.24

Handel in New York: S&P 500-Anleger greifen nachmittags zu

13.11.24

Aufschläge in New York: S&P 500 am Mittwochmittag im Plus

10.10.24

Anleger in New York halten sich zurück: S&P 500 fällt am Mittag zurück

25.09.24

Schwache Performance in New York: So entwickelt sich der S&P 500 am Mittwochmittag

12.08.24

Montagshandel in New York: S&P 500 beginnt die Montagssitzung in der Verlustzone

07.08.24

Handel in New York: S&P 500 fällt letztendlich zurück

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	28.71	3.53 %	K V
Swiss Life Hldg	711.80	1.74 %	K V
Swiss Re	132.60	1.07 %	K V
Zurich Insur Gr	542.20	0.63 %	K V
Holcim	87.76	0.46 %	K V
Alcon	76.28	-0.81 %	K V
Logitech Intl	74.40	-0.85 %	K V
Geberit	508.60	-1.17 %	K V
Sika	212.80	-1.39 %	K V
CieFinRichemont	135.25	-1.92 %	K V

Nachrichten zu Charles River Laboratories International Inc.

Aktien Top/Flop

Charles River Laboratories International Peer Group Nachrichten

Meistgelesene Nachrichten